DNA Investor Alert: Thornton Law Firm Announces Investigation

Boston, Massachusetts--(Newsfile Corp. - October 9, 2021) - The Thornton Law Firm alerts investors that it is investigating Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) for potential securities violations. Investors who currently own shares or options of DNA may contact the Thornton Law Firm's investor protection team by visiting www.tenlaw.com/cases/Ginkgo for more information. Investors may also email investors@tenlaw.com or call 617-531-3917.

FOR MORE INFORMATION: www.tenlaw.com/cases/Ginkgo

On October 6, 2021, short seller Scorpion Capital released a report alleging that Ginkgo Bioworks Holdings is a "colossal scam." The 175-page report alleges that Ginkgo Bioworks' business model is a "shell game," and that the company is highly dependent on related party transaction revenues. The report charges that the company is a "Frankenstein mash-up of the worst frauds of the last 20 years." Ginkgo Bioworks Holdings went public via a deSPAC transaction with blank check company Soaring Eagle Acquisition Corporation in September 2021. Shares of Ginkgo Bioworks have fallen 20% after publication of the report.

FOR MORE INFORMATION: www.tenlaw.com/cases/Ginkgo

Thornton Law Firm's securities attorneys are highly experienced in representing investors in recovering damages caused by violations of the securities laws. Its attorneys have established track records litigating securities cases in courts throughout the country and recovering losses on behalf of investors. This may be considered Attorney Advertising in some jurisdictions. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

CONTACT:
Thornton Law Firm LLP
1 Lincoln Street
State Street Financial Center
Boston, MA 02111
www.tenlaw.com/cases/Ginkgo

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/99087